all report title image

BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI750
  • Page number: 153
  • Formats:   Excel and PDF
  • Industry: Biotechnology
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Therapy Type
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Biosimilars Market, By Drug Class, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Recombinant Human Growth Hormone
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Granulocyte Colony-Stimulating Factor
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Insulin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Anticoagulants
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Fusion Proteins Erythropoietin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Monoclonal Antibodies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Follitropin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Biosimilars Market, By Therapy Type, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Immunology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Hematology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Hormone Therapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Metabolic Disorders
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Biosimilars Market, By Distribution Channel, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Specialty Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Biosimilars Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Samsung Bioepis Co., Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sandoz International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Celltrion Healthcare Co., Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Biocon Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Reddy's Laboratories Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Boehringer Ingelheim International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Fresenius Kabi AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Biogen Idec Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Coherus BioSciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Stada Arzneimittel AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology


    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Biosimilars Market” - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.